PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Statin therapy may prevent cancer by blocking inflammatory protein

Study results indicate that pitavastatin inhibits interleukin-33 to suppress skin and pancreatic cancers

2024-05-30
(Press-News.org) BOSTON –  A new study led by investigators from Mass General Cancer Center, a founding member of the Mass General Brigham healthcare system, reveals that statins—commonly used cholesterol-lowering drugs—may block a particular pathway involved in the development of cancer that results from chronic inflammation. The findings are published in Nature Communications.

“Chronic inflammation is a major cause of cancer worldwide,” said senior author Shawn Demehri, MD, PhD, a principal investigator at the Center for Cancer Immunology and Cutaneous Biology Research Center of Massachusetts General Hospital and an associate professor of Dermatology at Harvard Medical School. “We investigated the mechanism by which environmental toxins drive the initiation of cancer-prone chronic inflammation in the skin and pancreas,” says Demehri, who is also the Bob and Rita Davis Family MGH Research Scholar 2023-2028. “Furthermore, we examined safe and effective therapies to block this pathway in order to suppress chronic inflammation and its cancer aftermath.”

Demehri and his colleagues’ study relied on cell lines, animal models, human tissue samples and epidemiological data. The group’s cell-based experiments demonstrated that environmental toxins (such as exposure to allergens and chemical irritants) activate two connected signaling pathways called the TLR3/4 and TBK1-IRF3 pathways. This activation leads to the production of the interleukin-33 (IL-33) protein, which stimulates inflammation in the skin and pancreas that can contribute to the development of cancer.

When they screened a library of U.S. Food and Drug Administration–approved drugs, the researchers found that a statin, pitavastatin, effectively suppresses IL-33 expression by blocking the activation of the TBK1-IRF3 signaling pathway. In mice, pitavastatin suppressed environmentally-induced inflammation in the skin and the pancreas and prevented the development of inflammation-related pancreatic cancers.

In human pancreas tissue samples, IL-33 was over-expressed in samples from patients with chronic pancreatitis (inflammation) and pancreatic cancer compared with normal pancreatic tissue. Also, in analyses of electronic health records data on more than 200 million people across North America and Europe, use of pitavastatin was linked to a significantly reduced risk of chronic pancreatitis and pancreatic cancer.

The findings demonstrate that blocking IL-33 production with pitavastatin may be a safe and effective preventive strategy to suppress chronic inflammation and the subsequent development of certain cancers.

“Next, we aim to further examine the impact of statins in preventing cancer development in chronic inflammation in liver and gastrointestinal tract and to identify other novel, therapeutic approaches to suppress cancer-prone chronic inflammation” said Demehri.

 

Authorship: Jong Ho Park, Mahsa Mortaja, Heehwa G. Son, Xutu Zhao, Lauren M. Sloat, Marjan Azin, Jun Wang, Michael R. Collier, Krishna S. Tummala, Anna Mandinova, Nabeel Bardeesy, Yevgeniy R. Semenov, Mari Mino-Kenudson, and Shadmehr Demehri.

Disclosures: Disclosure forms provided by the authors are available with the full text of this article at https://doi.org/10.1038/s41467-024-48441-8.

Funding: Research support was provided by the Burroughs Wellcome Fund, the LEO Foundation, the Sidney Kimmel Foundation, and the National Institutes of Health.

Paper cited: Park JH et al. “Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression.” Nature Communications DOI:  10.1038/s41467-024-48441-8.

###

About Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. MGH is a founding member of the Mass General Brigham healthcare system.

END



ELSE PRESS RELEASES FROM THIS DATE:

A novel ‘senolytic’ strategy for treating aging-related diseases

A novel ‘senolytic’ strategy for treating aging-related diseases
2024-05-30
The process of aging is accompanied by a decline in physiological functions, which can lead to cardiovascular, neurodegenerative, and metabolic diseases. Aging of cells, also known as ‘cellular senescence’— is a process in which a cell ages and permanently stops dividing but does not die. The accumulation of such ‘senescent’ cells in tissues is then known to contribute to age-associated diseases. Elimination of senescent cells or ‘senolysis’ can, therefore, serve as an effective therapeutic strategy for the improvement of physiological function and prevention ...

Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later

2024-05-30
New findings on long COVID — long-term effects on health experienced by many who have had COVID-19 — present a good-news, bad-news situation, according to a study at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system. The bad news: COVID-19 patients who were hospitalized within the first 30 days after infection face a 29% higher risk of death in the third year compared with people who have not had the virus. However, the three-year death risk still marks a significant decline compared with such risk at the one- and two-year marks post-infection. The findings also show that even people with mild COVID-19 were still ...

Combining simulations and experiments to get the best out of Fe3Al

Combining simulations and experiments to get the best out of Fe3Al
2024-05-30
Osaka, Japan – The compound of iron and aluminum with the chemical formula Fe3Al has some very useful mechanical properties. A team from Osaka University has combined simulations with experimental techniques to better understand the kinetics of the formation of microstructures to enhance and utilize these properties and how to harness them for specific applications. In a study recently published in Acta Materialia, the researchers took an in-depth look at the way the microstructure of Fe3Al develops because the ordered domains that form contribute to one of its key properties: superelasticity. When high loads are applied to superelastic materials they ...

Both high performance and stability were achieved with multifunctional materials!

Both high performance and stability were achieved with multifunctional materials!
2024-05-30
 Through joint research with Professor Chul-jin Ahn’s team at Changwon National University, the research team of Dr. Jae-Ho Kim and Dr. Myung-kwan Song from the Department of Energy & Electronic Materials in the Surface & Nano Materials Division has developed a 4-Amino-TEMPO derivative with photocatalytic properties and successfully used it to produce high-performance and stable fiber-shaped dye-sensitized solar cells (FDSSCs) and fiber-shaped organic light-emitting diodes (FOLEDs). The developed 4-Amino-TEMPO derivative has the characteristic of simultaneously improving the performance of both fiber-shaped dye-sensitized solar cells (FDSSCs) and fiber-shaped ...

Structural inequities amplify homelessness challenges for pregnant people in Washington DC

2024-05-30
WASHINGTON -- New research conducted with Washington, DC, residents who experienced homelessness during pregnancy sheds light on the intersection of homelessness, pregnancy, and racial inequities. The findings underscore the urgent need for policy and practice changes to support vulnerable populations. The study, published May 30, 2024 in the journal Health Equity (DOI: 10.1089/heq.2023.0235), is grounded in a reproductive justice framework and delves into the lived experiences of 20 DC residents who faced homelessness while pregnant. Homelessness ...

University of Maryland study shows N95 masks near-perfect at blocking escape of airborne COVID-19

2024-05-30
COLLEGE PARK, Md. – In a head-to-head comparison of masks worn by people with active COVID-19, the inexpensive “duckbill” N95 came out on top, stopping 98% of COVID-19 particles in the breath of infected people from escaping into the air. Led by researchers from the University of Maryland School of Public Health (SPH), results showed other masks also performed well, blocking at least 70% of viral particles from escaping from the source – an infected person’s exhaled breath. The study, Relative efficacy of masks and respirators as source control for viral aerosol shedding from people infected with SARS-CoV-2, published May 29 in eBioMedicine, a Lancet ...

The AI paradox: Building creativity to protect against AI

2024-05-30
Cultivating creativity in schools is vital for a future driven by artificial intelligence (AI). But while teachers embrace creativity as an essential 21st century skill, a lack of valid and reliable creativity tests means schools struggle to assess student achievement.   Now, a new machine-learning model developed by the University of South Australia is providing teachers with access to high-quality, fit-for-purpose creativity tests, that can score assessments in a fraction of the time and a fraction of the cost.   Applied to the current ...

Visible light-induced photocatalysis–self-Fenton degradation of P-Clphoh over graphitic carbon nitride by a polyethylenimine bifunctional catalyst

Visible light-induced photocatalysis–self-Fenton degradation of P-Clphoh over graphitic carbon nitride by a polyethylenimine bifunctional catalyst
2024-05-30
The deep degradation of organic pollutants through solar light-coupled photocatalysis and the Fenton reaction (Photo-Fenton) holds significant importance in the field of water purification. In this study, a novel bifunctional catalyst (Fe-PEI-CN) was synthesized by electrostatic self-assembly and hydrothermal methods, doping graphene-like carbon nitride (CN) with polyethyleneimine (PEI) and iron (Fe) species. This catalyst efficiently degraded p-chlorophenol (p-ClPhOH) by generating hydrogen peroxide (H2O2) during the photocatalytic process. The relationship between catalytic efficiency and structure was explored using various characterization techniques.Under ...

Engineered DNA 'warhead' targets a common cancer mutation

Engineered DNA warhead targets a common cancer mutation
2024-05-30
Tumour protein P53 (TP53) plays an important role in suppressing the growth of tumours. Mutations in the gene for TP53 can have a disastrous effect, hampering the body's ability to fight tumours and even encouraging their growth. Because these are the most common mutations in cancers, TP53 has long been an interesting therapeutic target. However, efforts to destroy the mutant protein have been hampered by the difficulty of finding a way to bind to it. Now, a team of researchers from Xi'an ...

Picture this: Snapping photos of our food could be good for us

2024-05-30
New Curtin University research reveals taking pictures of food isn’t just content for our social media feeds, but could be the key to improving people’s diets.   Published in the prestigious American Journal of Clinical Nutrition, the feeding study saw researchers measure the weight of meals, which were then provided to participants over a day for breakfast, lunch and dinner.   Participants compared different technology-assisted methods to recall what they had eaten over the past 24 hours.    One method asked participants to take photos of their meals using the mobile Food Record app.   These ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Statin therapy may prevent cancer by blocking inflammatory protein
Study results indicate that pitavastatin inhibits interleukin-33 to suppress skin and pancreatic cancers